GAMMACEL
Dead / Abandoned — Abandoned — no statement of use filed (as of 05 Feb 2024)
What this means for you
This application is over — abandoned 05 Feb 2024. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97194538
- Mark type
- Stylized text
- Filed
- 29 Dec 2021
- Published for opposition
- 08 Nov 2022
- Abandoned
- 05 Feb 2024
- Attorney of record
- Karen Won
Goods and services
- Class 042 — Scientific and technological services: Pharmaceutical research and development; Pharmaceutical research services; Research and development in the pharmaceutical and biotechnology fields; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer
Owner
- Kiromic Biopharma, Inc., Houston, TX, AD
- Kiromic Biopharma, Inc., Houston, TX, AD
Prosecution history
- 05 Feb 2024 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 05 Feb 2024 — ABANDONMENT - NO USE STATEMENT FILED
- 20 Jun 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 16 Jun 2023 — SOU EXTENSION 1 GRANTED
- 16 Jun 2023 — SOU EXTENSION 1 FILED
- 16 Jun 2023 — SOU TEAS EXTENSION RECEIVED
- 03 Jan 2023 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 08 Nov 2022 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 08 Nov 2022 — PUBLISHED FOR OPPOSITION
- 19 Oct 2022 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 05 Oct 2022 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 03 Oct 2022 — ASSIGNED TO EXAMINER
- 18 May 2022 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 18 May 2022 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 18 May 2022 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED